Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Risk of bleeding"'
Autor:
Hamad Albagieh, Asim Alosimi, Abdulrahman Aldhuhayan, Abdulrahman AlAbdulkarim, Bader Fatani, Abdulaziz Alabood
Publikováno v:
Saudi Dental Journal, Vol 36, Iss 2, Pp 270-276 (2024)
Background: The kidneys carry out many essential processes. A reduced glomerular filtration rate is the primary cause of renal failure. Patients with chronic kidney disease are significantly increasing all around the world. Patients with varying degr
Externí odkaz:
https://doaj.org/article/a7c092ab43d84a9f8aebcadc21f12ab7
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-9 (2024)
Abstract Purpose The choice of continuous renal replacement therapy (CRRT) anticoagulation program for patients at high risk of bleeding has always been a complex problem in clinical practice. Clinical regimens include regional citrate anticoagulatio
Externí odkaz:
https://doaj.org/article/ac518dd8792044a1a074b65a1e9c2c85
Autor:
S. L. Konstantinov, G. I. Stryabkova, A. I. Basarab, V. N. Kravchuk, I. V. Kаzhanov, S. V. Ivanov, Zh. Yu. Chefranova, S. S. Markin
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 5, Pp 495-501 (2023)
A case report of double thrombolytic therapy with non-immunogenic staphylokinase at a dose of 15 mg bolus over 15 s in a patient with a high-risk massive pulmonary embolism (PE) in the early postoperative period due to femoral wound is described. Aft
Externí odkaz:
https://doaj.org/article/00a80b5d525a478184b93f381c75a380
Autor:
N. M. Vorobyeva, O. N. Tkacheva
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 1, Pp 101-106 (2023)
The review article discusses the safety issue of anticoagulant therapy in elderly patients with atrial fibrillation and high risk of bleeding. An evidence base is presented demonstrating the high safety of rivaroxaban in patients over 80 years of age
Externí odkaz:
https://doaj.org/article/b4c91ebd58e34d13b119c4470f12ada6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Juan YUAN
Publikováno v:
Zhongguo shuxue zazhi, Vol 35, Iss 1, Pp 39-42 (2022)
Objective To compare the therapeutic effects of low molecular weight heparin sodium and sodium citrate on hemodialysis(HD) patients at high risk of bleeding. Method A total of 96 patients at high risk of bleeding on maintenance hemodialysis from May
Externí odkaz:
https://doaj.org/article/b686b280eeff46d88897b40cddd54f84
Publikováno v:
Studia Medyczne, Vol 36, Iss 1, Pp 51-59 (2020)
Interruption of long-term therapy with oral anticoagulants in patients undergoing elective surgical procedures is a common problem in clinical practice. A large number of patients are receiving oral anticoagulants due to atrial fibrillation, mechanic
Externí odkaz:
https://doaj.org/article/63be2565a9914351a58638644a8b1ac2
Autor:
Carmen Gabriela Stelea, Emilia Dîmbu, Sorin Andrian, Oana Elena Ciurcanu, Alexandra Lorina Stelea, Cristina Bologa
Publikováno v:
Romanian Journal of Oral Rehabilitation, Vol 10, Iss 3, Pp 103-108 (2018)
Aim of the study: The management of patients undergoing chronic oral anticoagulation raises concerns regarding the postoperative bleeding risk. In the last few years, new oral anticoagulants were released on the market, but the operative protocols fo
Externí odkaz:
https://doaj.org/article/b122512a7cff46f5af4a068373ce0665
Autor:
N. Yu. Velts, M. A. Darmostukova, A. S. Kazakov, T. M. Bukatina, O. E. Zhuravleva, R. N. Alyautdin, B. K. Romanov
Publikováno v:
Безопасность и риск фармакотерапии, Vol 0, Iss 2, Pp 28-32 (2018)
One of the main causes of death and disability in the world are the thrombotic complications. Using of anticoagulants is the effective method of preventing of these life-threatening conditions. However, the use of anticoagulants involves a significan
Externí odkaz:
https://doaj.org/article/d3bc133477e94d0cb08711e125546262
Autor:
M. Yu. GILYAROV, E. V. KONSTANTINOVA
Publikováno v:
Атеротромбоз, Vol 0, Iss 2, Pp 21-31 (2017)
After percutaneous coronary intervention, patients receive double antiplatelet therapy for several months, which includes acetylsalicylic acid and a P2Y12 receptor inhibitor. In most cases, managing the patients with the atrial fibrillation requires
Externí odkaz:
https://doaj.org/article/c1b3fd16061841f1bbc7fba5381f9725